Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01759420 · ClinicalTrials.gov registry record
Ondansetron and the QT Interval In Adult Emergency Department Patients
A clinical trial, sponsored by C.R.Darnall Army Medical Center.
- Completed
- Registry status
- 28
- Enrollment target
NCT01759420 is a clinical trial that has completed, run by C.R.Darnall Army Medical Center. The registered enrollment target is 28 participants.
The verdict
NCT01759420 has completed, sponsored by C.R.Darnall Army Medical Center.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the use of the medication ondansetron (zofran) in the emergency department. There are studies of the ability of ondansetron to cause a prolongation in the QT interval (a certain measurement on an EKG) in anesthesia and cancer patients, but not on emergency department patients. This is an observational study where patients that are going to receive the anti-nausea medicine ondansetron in the emergency department will have an EKG performed every 2 minutes for 20 minutes to determine if the QT interval prolongs and returns to normal in that time period. Any serious outcomes will be reported. There is expected to be no adverse outcomes from this routinely used medication.
Interventions
- DRUG Ondansetron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01759420
The ClinicalTrials.gov registry entry for NCT01759420 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C.R.Darnall Army Medical Center, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ondansetron is the first listed.
NCT01759420 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01759420 about?
NCT01759420 is a clinical study titled "Ondansetron and the QT Interval In Adult Emergency Department Patients". The purpose of this study is to assess the use of the medication ondansetron (zofran) in the emergency department. There are studies of the ability of ondansetron to cause a prolongation in the QT interval (a certain measurement on an EKG) in anesthesia and cancer patients, but not on emergency depa...
What is the current status of trial NCT01759420?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2012-12. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01759420?
The interventions under investigation include: Ondansetron (DRUG).
Who is sponsoring clinical trial NCT01759420?
This trial is sponsored by C.R.Darnall Army Medical Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.